We are live on ! Find out more
DIM

DLK Investment Management Portfolio holdings

AUM $235M
1-Year Est. Return 12.41%
This Fund
S&P 500
This Quarter Est. Return
+3.04%
1 Year Est. Return
+12.41%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$242M
AUM Growth
+$6.7M
Cap. Flow
+$2.22M
Cap. Flow %
0.92%
Top 10 Hldgs %
39.82%
Holding
119
New
10
Increased
51
Reduced
19
Closed
8

Top Sells

Rank Stock Value
1
COST icon
Costco
COST
+$2.46M
2
AAPL icon
Apple
AAPL
+$1.07M
3
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$674K
4
TSLA icon
Tesla
TSLA
+$591K
5
GE icon
GE Aerospace
GE
+$554K

Sector Composition

Rank Sector Weight
1 Technology 21.62%
2 Healthcare 15.48%
3 Industrials 12.37%
4 Consumer Staples 12.14%
5 Financials 11.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHPW
101
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
$11.9K ﹤0.01%
16,825
+700
+4% +$944
AREN icon
102
Arena Group
AREN
$105M
$10.6K ﹤0.01%
13,800
+3,000
+28% +$2.42K
BNGO icon
103
Bionano Genomics
BNGO
$13.3M
$8.37K ﹤0.01%
206
AUROW
104
Aurora Innovation Warrant
AUROW
$335M
$7.92K ﹤0.01%
38,262
RVMDW icon
105
Revolution Medicines Inc Warrant
RVMDW
$127M
$7.86K ﹤0.01%
77,000
ME
106
DELISTED
23andMe Holding Co
ME
$7.18K ﹤0.01%
917
+100
+12% +$957
DNA icon
107
Ginkgo Bioworks
DNA
$500M
$6.17K ﹤0.01%
462
+150
+48% +$4.47K
CLDI icon
108
Calidi Biotherapeutics
CLDI
$3.99M
$4.16K ﹤0.01%
+11
New +$5.62K
AKTS
109
DELISTED
Akoustis Technologies Inc
AKTS
$3.75K ﹤0.01%
28,500
+7,000
+33% +$2.64K
LYRA
110
DELISTED
LYRA THERAPEUTICS INC
LYRA
$3.32K ﹤0.01%
240
PRST
111
DELISTED
Presto Technologies, Inc. Common Stock
PRST
$700 ﹤0.01%
10,000
BEAM icon
112
Beam Therapeutics
BEAM
$2.82B
-7,225
Closed -$239K
BIDU icon
113
Baidu
BIDU
$37.1B
-2,310
Closed -$243K
BSV icon
114
Vanguard Short-Term Bond ETF
BSV
$45.6B
-8,785
Closed -$674K
GEHC icon
115
GE HealthCare
GEHC
$32.9B
-2,513
Closed -$228K
HOOK
116
DELISTED
HOOKIPA Pharma
HOOK
-3,200
Closed -$22.8K
NUTX
117
Nutex Health
NUTX
$1.35B
-255
Closed -$3.67K
DM
118
DELISTED
Desktop Metal, Inc.
DM
-5,567
Closed -$49K
OMIC
119
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
-833
Closed -$12.9K

Similar funds

DLK Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, DLK Investment Management held 119 positions worth $242M, up 2.8% from $235M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

DLK Investment Management's Q2 2024 filing shows 10 new, 51 increased, 19 reduced and 8 closed positions. Its largest new stake was Mastercard: 945 shares worth $417K. The largest sale was Costco, an estimated $2.46M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.

  • DLK Investment Management's largest Q2 2024 buy was Mastercard: 945 shares worth $417K.
  • DLK Investment Management added most to Nike in Q2 2024, an estimated $1.47M increase.
  • DLK Investment Management's biggest Q2 2024 reduction was Costco, cutting an estimated $2.46M.
  • DLK Investment Management fully exited Vanguard Short-Term Bond ETF in Q2 2024, selling an estimated $674K.
  • DLK Investment Management's ten largest holdings make up 40% of its $242M portfolio in Q2 2024.
  • DLK Investment Management opened 10 new positions and closed 8 in Q2 2024.
  • DLK Investment Management's portfolio value rose 2.8% quarter-over-quarter to $242M.

Based on DLK Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.